HOME › DRUGS › QUIZARTINIB
ACTIVE SUBSTANCE / INN

QUIZARTINIB

Brand name(s): Vanflyta
EMA LISTED
REFUSED
AUTHORISED
Leukemia, Myeloid, Acute
Leukemia, Myeloid
ACTIVE SUBSTANCE
Quizartinib
REGULATORS
EMA
SPONSORS / MAH
Daiichi Sankyo Europe GmbH
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VanflytaDaiichi Sankyo Europe GmbHAuthorised06/11/2023Leukemia, Myeloid
VanflytaDaiichi Sankyo Europe GmbHRefusedLeukemia, Myeloid, Acute

FULL INTELLIGENCE ON QUIZARTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →